Gait Analysis in Neurologic Disorders, Methodology, Applications and Clinical Considerations
Neurol 105:e214154, Ali,F.,et al, 2025
National Randomized Controlled Trial of Virtual House Calls for Parkinson Disease
Neurol 89:1152-1161,1103, Beck, C.A.,et al, 2017
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
Pract Neurology 4:50-55, Razvi,S.S.M. &Muir,K.W., 2004
Donepezil for Cognitive Impairment in Parkinson's Disease: A Randomised Controlled Study
JNNP 72:708-712, Aarsland,D.,et al, 2002
Effects of Bilateral Subthalamic Stimulation on Cognitive Function in Parkinson Disease
Arch Neurol 58:1223-1227,1205, Alegret,M.,et al, 2001
Neuropsychological Consequences of Posteroventral Pallidotomy for the Treatment of Parkinson's Disease
Neurol 51:207-215, Trepanier,L.L.,et al, 1998
Cognitive Functioning After Pallidotomy for Refractory Parkinson's Disease
JNNP 65:150-154, 1481998., Perrine,K.,et al, 1998
Motor, Cognitive, and Behavioral Performance Following Unilateral Ventroposterior Pallidotomy for Parkinson Disease
Arch Neurol 55:1201-1208, Masterman,D.,et al, 1998
Frequency of Dementia in Parkinson Disease
Arch Neurol 42:428-431, Aarsland,D.,et al, 1996
Reversible Parkinsonism and Cognitive Impairment with Chronic Valproate Use
Neurol 47:626-635, Armon,C.,et al, 1996
Unusual Clinical Presentations of Cortical-Basal Ganglionic Degeneration
Ann Neurol 40:893-900, Bergeron,C.,et al, 1996
Neurological Sequelae of Cyanide Intoxication-The Patterns of Clinical MRI & Pet Findings
Ann Neurol 38:825-828, Rosenow,F.,et al, 1995
Parkinson's Disease
JNNP 57:672-681, Marsden,C.D., 1994
Extrapyramidalism in Alzheimer's Disease:Prevalence, Psychiatric and Neuropsychological Correlates
JNNP 57:1503-1509, Merello,M.,et al, 1994
Aspartame Use in Parkinson's Disease
Neurol 43:611-613, Karstaedt,P.J.&Pincus,J.H., 1993
Risk Factors for Nursing Home Placement in Advanced Parkinson's Disease
Neurol 43:2227-2229, Goetz,C.G.&Stebbins,G.T., 1993
Cognitive Change Following MPTP Exposure
Neurol 40:261-264, Stern,Y.,et al, 1990
The Olfactory and Cognitive Deficits of Parkinson's Disease:Evidence for Independence
Ann Neurol 25:166-171, Doty,R.L.,et al, 1989
Cognitive Impairments Associated with Early Parkinson's Disease
Neurol 39:557-561, Levin,B.E.,et al, 1989
Clinical and Pathological Aspects of Parkinsonism in Alzheimer's Disease, A Role for Extranigral Factors?
Arch Neurol 46:651-657, Morris,J.C.,et al, 1989
Neuropsychological Effects of Brain Autograft of Adrenal Medullary Tissue for Treatment of Parkinson's Disease
Neurol 38:1442-1450, Ostrosky-Solis,F.,et al, 1988
Dementia and Cognitive Impairment in Parkinson's Disease
JNNP 51:1498-1502, Girotti,F.,et al, 1988
Neuropsychological Disturbances in Hemiparkinson's Disease
Neurol 37:1762-1764, Starkstein,S.,et al, 1987
Depression, Intellectual Impairment & Parkinson Disease
Neurol 31:645-650, Mayeux,R.,et al, 1981
The Effect of Symptom Duration on Cognitive & Motor Performance in Parkinsonism
Neurol 29:951-956, Matthews,C.G.,et al, 1979
Acquired Stuttering
Neurol 28:1159-1165, Helm,N.A.,et al, 1978